跳至主要内容
临床试验/LBCTR2021124932
LBCTR2021124932尚未招募不适用

A MULTI-COUNTRY OBSERVATIONAL RETROSPECTIVE STUDY TO EVALUATE THE PREVALENCE OF PD-L1 AND ITS ROLE IN PATIENTS WITH TNBC TREATED WITH SYSTEMIC THERAPY - Vanessa

F. HOFFMANN-LA ROCHE LTD0 个研究点目标入组 40 人开始时间: 2024年4月15日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 100(—)
性别
All

入选标准

  • Patients must meet the following criteria for enrolment in this registry:
  • - Patient is an adult (according to age of majority as defined by local regulations)
  • - Patient is currently diagnosed with any type of solid tumor cancer, at any stage of the disease, at the enrolment date (informed consent date)
  • - Patient has undergone NGS testing, no longer than 3 months prior to the enrolment date, irrespective of the availability of test results
  • - Informed consent has been obtained from the patient or legally authorized representative, as per local regulations

排除标准

  • Patients who meet the below exclusion criterion at the time of enrolment will not be enrolled in this registry:
  • - Patient has a prior or current diagnosis of hematological malignancy

研究者

相似试验